Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations > Corporate Governance > Insider Transactions

Insider Transactions

Date Name Title Type Shares Traded Price Range
Sep 5, 2012 shrotriya rajesh c md Officer Automatic Sell 33,000 12.53
Sep 4, 2012 maida anthony e iii Director Automatic Sell 5,000 12.01
Sep 4, 2012 maida anthony e iii Director Option Execute 5,000 6.65
Aug 17, 2012 krassner stuart mitchell Director Sell 5,750 12.58
Aug 16, 2012 shrotriya rajesh c md Officer Automatic Sell 84,000 12.61
Aug 15, 2012 shrotriya rajesh c md Officer Automatic Sell 83,000 12.54
Aug 14, 2012 shrotriya rajesh c md Officer Automatic Sell 41,500 12.53
Aug 9, 2012 shrotriya rajesh c md Officer Option Execute 75,000 1.06
Jul 13, 2012 krassner stuart mitchell Director Sell 5,000 16.27 - 16.61
Jul 12, 2012 shrotriya rajesh c md Officer Option Execute 68,027 1.47
Mar 27, 2012 gagnon gilles Director Statement of Ownership 0 n/a
Mar 27, 2012 gueth anton Director Statement of Ownership 0 n/a
Mar 6, 2012 maida anthony e iii Director Sell 2,500 12.70
Mar 6, 2012 maida anthony e iii Director Option Execute 2,500 2.55
Mar 5, 2012 maida anthony e iii Director Sell 3,200 12.83
Mar 5, 2012 maida anthony e iii Director Option Execute 3,200 2.55
Jan 14, 2012 shrotriya rajesh c md Officer Disposition (Non Open Market) 16,848 14.63
Dec 29, 2011 shrotriya rajesh c md Officer Option Execute 205,836 1.43 - 5.53
Dec 23, 2011 scott brett l Officer Acquisition (Non Open Market) 86,500 14.77
Dec 23, 2011 scott brett l Officer Disposition (Non Open Market) 40,179 14.77
Showing 181-200 of 267 transactions Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14  See Previous 20 | See Next 20

Stock transaction information provided by EDGAR Online. Spectrum Pharmaceuticals, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
19.50
Change:
- 1.23
Day High:
21.00
Day Low:
19.10
Volume:
2,141,818
4:00 PM ET on Nov 17, 2017
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR